Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4/A Registration of securities issued in business combination transactions
- 8.1 Opinion of Foley & Lardner LLP, Counsel of Morphogenesis, Inc.
- 8.2 Opinion of Gibson, Dunn & Crutcher LLP, Counsel of Cohbar, Inc
- 10.28 Exclusive License Agreement, Dated April 23, 2021, Between Morphogenesis, Inc. and H. Lee Moffitt Cancer and Research Institute, As Amended
- 10.29 Restated and Amended Exclusive License Agreement, Dated September 7, 2022, Between Morphogenesis, Inc. and West Virginia Research Corporation
- 23.1 Consent of Marcum LLP, Independent Registered Public Accounting Firm of Cohbar, Inc
- 23.2 Consent of Cherry Bekaert LLP, Independent Registered Public Accounting Firm of Morphogenesis, Inc
- 99.1 Form of Cohbar, Inc. Proxy Card
- Download Excel data file
- View Excel data file
Associated filings
- 13 Sep 23 EFFECT Notice of effectiveness
- 12 Sep 23 424B3 Prospectus supplement
- 12 Sep 23 S-4/A Registration of securities issued in business combination transactions (amended)
-
29 Aug 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 10 Aug 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 30 Jun 23 S-4 Registration of securities issued in business combination transactions
CWBR similar filings
Filing view
External links
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the inclusion in the Amendment No. 2 to this Registration Statement on Form S-4 of CohBar, Inc. of our report dated February 17, 2023, related to the consolidated financial statements of Morphogenesis, Inc. as of and for the years ended December 31, 2022 and 2021, and to the reference to us under the heading “Experts” in the Amendment No. 2 to this Registration Statement.
/s/ Cherry Bekaert LLP
Tampa, Florida
August 30, 2023